Related Articles
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
Aberrant expression of NEK2 and its clinical significance in non‑small cell lung cancer
NIMA‑related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation
Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation
Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma